Anbio Biotechnology (NASDAQ:NNNN) Sees Large Volume Increase – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) saw unusually-strong trading volume on Monday . 76,536 shares were traded during mid-day trading, an increase of 44% from the previous session’s volume of 53,183 shares.The stock last traded at $7.6220 and had previously closed at $6.81.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Anbio Biotechnology Stock Performance

The company’s fifty day moving average is $11.03 and its 200-day moving average is $20.37.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.